Anti-inflammatory effects of eupatilin on Helicobacter pylori CagA-induced gastric inflammation
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0313251 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Bong Eun Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea. Hauptthemen laut MEDLINE: Antigens, Bacterial, Bacterial Proteins, Flavonoids, Helicobacter pylori. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dong-A Pharmaceutical Co. Ltd, National Research Foundation of Korea.
Abstract (Originalsprache)
Background
Eupatilin, a flavone isolated from Artemisia species, exerts anti-inflammatory, anti-oxidative, and anti-neoplastic activities. However, the effects of eupatilin on H . pylori -associated gastritis remain unclear. Thus, this study aimed to investigate the anti-inflammatory effects of eupatilin on gastric epithelial cells infected with cytotoxin-associated gene A (CagA)-positive Helicobacter pylori . Materials and methods AGS human gastric carcinoma cells were infected with a CagA-positive H . pylori strain and then treated with 10, 50, or 100 ng of eupatilin. After 24 h, the expression levels of CagA, phosphoinositide 3-kinase 1 (PI3K), nuclear factor (NF)-κB, interleukin (IL)-1β, and tumor necrosis factor (TNF)-α in the cell lysates were measured using western blotting, and the mRNA levels of IL-6, IL-8, and monocyte chemoattractant protein (MCP)-1 were measured using real-time polymerase chain reaction.
Results
CagA translocation into AGS cells resulted in an elongated cell morphology, which was significantly suppressed by eupatilin treatment in a dose-dependent manner. Immunofluorescence staining for anti-CagA showed that eupatilin treatment dose-dependently inhibited CagA expression in the H . pylori -infected AGS cells. H . pylori infection increased the levels of pro-inflammatory cytokines including IL-1β, TNF-α, IL-6, IL-8, and MCP-1, and eupatilin treatment significantly reduced the levels of these cytokines in a dose-dependent manner. Additionally, eupatilin treatment dose-dependently suppressed the expression of PI3K and NF-κB.
Conclusions
Eupatilin treatment demonstrated anti-inflammatory effects on CagA-positive H . pylori -infected gastric epithelial cells by inhibiting CagA translocation, thereby suppressing the NF-κB signaling pathway. These results suggest that eupatilin plays a protective role against CagA-positive H . pylori -induced gastritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
- Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
ORCID-Profile: Bong Eun Lee, Gwang Ha Kim
Förderung
- Dong-A Pharmaceutical Co. Ltd
- National Research Foundation of Korea
Zitieren
APA
Lee, B. E., Park, S. J., Kim, G. H., Joo, D. C., & Lee, M. W. (2024). Anti-inflammatory effects of eupatilin on Helicobacter pylori CagA-induced gastric inflammation. PLOS ONE. https://doi.org/10.1371/journal.pone.0313251
Vancouver
Lee BE, Park SJ, Kim GH, Joo DC, Lee MW. Anti-inflammatory effects of eupatilin on Helicobacter pylori CagA-induced gastric inflammation. PLOS ONE. 2024. doi:10.1371/journal.pone.0313251
BibTeX
@article{Lee2024,
author = {Lee, Bong Eun and Park, Su Jin and Kim, Gwang Ha and Joo, Dong Chan and Lee, Moon Won},
title = {Anti-inflammatory effects of eupatilin on Helicobacter pylori CagA-induced gastric inflammation},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0313251}
}
EUVIMED